We have observed
17 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 19, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
ANTIBACTERIAL PIPERIDINYL SUBSTITUTED 3,4-DIHYDRO-1H-[1,8]NAPHTHYRIDINONES
ANTIBACTERIAL CYCLOPENTA[C]PYRROLE SUBSTITUTED 3,4-DIHYDRO-1H-[1,8]NAPHTHYRIDINONES
ANTIBACTERIAL HOMOPIPERIDINYL SUBSTITUTED 3,4 DIHYDRO 1H [1,8]NAPHTHYRIDINONES
PROCESSES AND INTERMEDIATES FOR PREPARING A MACROCYCLIC PROTEASE INHIBITOR OF HCV
IMPROVED PROCESS FOR PREPARING AN INTERMEDIATE OF THE MACROCYCLIC PROTEASE INHIBITOR TMC 435
HIV inhibiting 5,6-substituted pyrimidines
ANTIBACTERIAL QUINOLINE DERIVATIVES
NEW ANTIBACTERIAL COMPOUNDS
Macrocylic inhibitors of hepatitis c virus
PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF BACTERIAL DISEASES
PROCESSES AND INTERMEDIATES FOR PREPARING A MEDICAMENT
AMORPHOUS SALT OF A MACROCYCLIC INHIBITOR OF HCV